JPET Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 26, 2006; DOI: 10.1124/jpet.106.103747


0022-3565/06/3183-1368-1374$20.00
JPET 318:1368-1374, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow An erratum has been published
Right arrow All Versions of this Article:
jpet.106.103747v1
318/3/1368    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Topal, G.
Right arrow Articles by David-Dufilho, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Topal, G.
Right arrow Articles by David-Dufilho, M.

CARDIOVASCULAR

Mitochondrial Arginase II Modulates Nitric-Oxide Synthesis through Nonfreely Exchangeable L-Arginine Pools in Human Endothelial Cells

Gökce Topal, Annie Brunet, Laurence Walch, Jean-Luc Boucher, and Monique David-Dufilho

Centre National de la Recherche Scientifique, Université Pierre et Marie Curie-Paris 6, Unité Mixte de Recherche 7131, Paris, France (J.-L.G.T., A.B., L.W., M.D.-D.); and Centre National de la Recherche Scientifique, (J.-L.B.)

Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and mitochondrial arginase II. To determine whether arginases modulate the endothelial NO synthesis, we investigated the effects of the competitive arginase inhibitor N{omega}-hydroxy-nor-L-arginine (Nor-NOHA) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs). In unstimulated cells, Nor-NOHA dose-dependently reduced the arginase activity with maximal inhibition at 20 µM. When HUVECs were stimulated by thrombin without extracellular L-arginine, Nor-NOHA dose-dependently increased the NOS activity and the NO release with maximal effects at 20 µM. Extracellular L-arginine also dose-dependently increased NO release and arginase activity. When HUVECs were stimulated by thrombin in the presence of 100 µM L-arginine, NOS activity and NO release were similar in untreated and Nor-NOHA-treated cells. However, despite activation of L-arginine uptake, the inhibition of arginase activity by Nor-NOHA was still significant. The depletion of freely exchangeable L-arginine pools with extracellular L-lysine did not prevent Nor-NOHA from increasing the NO release. This indicates the presence of pools, which are accessible to NOS and arginase, but not exchangeable. Interestingly, the mitochondrial arginase II was constitutively expressed, whereas the cytosolic arginase I was barely detectable in HUVECs. These data suggest that endothelial NO synthesis depends on the activity of arginase II in mitochondria and L-arginine carriers in cell membrane.


Received February 27, 2006; accepted June 23, 2006.

Address correspondence to: Monique David-Dufilho, Unité Mixte de Recherche 7131, Centre National de la Recherche Scientifique-UPMC, Groupe Hospitalier HEGP-Broussais, 102 rue Didot, 75014 Paris, France. E-mail: Monique.dufilho{at}brs.aphp.fr




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Lim, H. K. Lim, S. Ryoo, A. Benjo, K. Shuleri, V. Miriel, E. Baraban, A. Camara, K. Soucy, D. Nyhan, et al.
Mitochondrial arginase II constrains endothelial NOS-3 activity
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3317 - H3324.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. M. Johann, V. Barra, A.-M. Kuhn, A. Weigert, A. von Knethen, and B. Brune
Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production
FASEB J, September 1, 2007; 21(11): 2704 - 2712.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. A. Holowatz and W. L. Kenney
Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans
J. Physiol., June 1, 2007; 581(2): 863 - 872.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.